Advancing ophthalmic research through transparent, ethically designed scientific collaboration.
Complex eye diseases cannot always be understood through a single structure, biomarker, or treatment target.
Netra Eye Institute is interested in collaborating with researchers and organizations investigating the relationships among ocular circulation, neural function, metabolism, inflammation, oxidative stress, mitochondrial health, autonomic regulation, pain processing, and functional vision.
Our goal is to develop responsible research partnerships that examine Netra Restoration Therapy using transparent methodology, appropriate outcome measures, and independent scientific review.
We welcome inquiries from:
Collaborations may involve a single investigator, a multidisciplinary team, or an institutional partnership.
Potential projects may investigate:
NRT is not intended to replace intraocular-pressure management. Any glaucoma research should preserve standard pressure-lowering treatment and ophthalmologic monitoring.
Research interests include:
Potential endpoints may include imaging, visual acuity, contrast sensitivity, reading function, low-luminance performance, patient-reported outcomes, and treatment burden.
Potential areas include:
Research should clearly distinguish symptomatic or functional changes from modification of the underlying genetic disorder. Possible projects may examine visual function, quality of life, adaptation, contrast, light sensitivity, reading performance, imaging, and electrophysiology.
Research opportunities may examine:
Collaborative studies may incorporate symptom scales, esthesiometry, confocal microscopy, tear analysis, pain-processing measures, and quality-of-life instruments.
We are interested in evaluating possible relationships among NRT and:
These areas should be approached as testable hypotheses and not as predetermined conclusions.
A retrospective review may analyze existing clinical records to identify patient characteristics, conditions treated, treatment completion, outcome patterns, safety observations, variables associated with response, and areas requiring prospective study.
All retrospective research should undergo appropriate ethical, privacy, and institutional review.
Prospective studies may use predefined eligibility criteria, treatment schedules, assessment intervals, outcome measures, imaging protocols, patient-reported questionnaires, and follow-up periods.
This approach can improve consistency and reduce limitations associated with retrospective data.
Carefully documented case reports may be appropriate for unusual presentations, unexpected findings, or early clinical observations. A publishable case should include:
Potential collaborative tools may include optical coherence tomography, OCT angiography, fundus photography, visual-field testing, contrast-sensitivity testing, reading-performance measures, dark-adaptation testing, electrophysiology, corneal confocal microscopy, and functional vision questionnaires.
Collaborating institutions may provide testing capabilities not currently available at Netra Eye Institute.
Research organizations with laboratory capabilities may investigate blood-, tear-, or tissue-related markers associated with inflammation, oxidative stress, metabolic activity, vascular function, mitochondrial health, neurotrophic signaling, and stress physiology.
Any biomarker project should be based on a predefined scientific rationale and appropriate laboratory methods.
When preliminary evidence supports further investigation, a pilot study may evaluate feasibility, recruitment, adherence, safety, measurement selection, effect-size estimates, variability, and follow-up requirements.
Pilot studies can provide the information needed to design larger controlled investigations.
The scope of participation must be defined in a written research agreement, and the responsibilities of each party should be agreed upon before recruitment or data collection begins.
All collaborative research must prioritize participant rights, scientific integrity, privacy, and transparency. Depending on the project, requirements may include:
Participation in treatment should not be conditioned on participation in research unless clearly permitted within an approved protocol.
Research involving NRT must not require participants to discontinue medically necessary conventional treatment. Participants should continue care recommended by their ophthalmologist or other treating physician, including:
Any changes to conventional treatment must be made by the appropriate treating physician.
Netra Eye Institute supports responsible publication of research findings, including results that are neutral, inconclusive, or inconsistent with the original hypothesis.
Research agreements should address:
Scientific conclusions should reflect the data and study design rather than promotional objectives.
Researchers interested in collaborating are invited to submit a preliminary inquiry using the form below.
After receiving a research inquiry, Netra Eye Institute may:
Submission of an inquiry does not guarantee acceptance of a proposed project.
Progress requires collaboration between clinicians who observe emerging patterns and researchers who can investigate those observations through rigorous scientific methods. Netra Eye Institute welcomes serious, ethically designed research partnerships focused on understanding visual function, ocular physiology, patient outcomes, and the scientific evaluation of Netra Restoration Therapy.
Submit a Research Collaboration Inquiry Learn About the Scientific Rationale for NRTThe presence of a research hypothesis, proposed mechanism, case observation, or collaboration does not establish clinical efficacy.
Research activities must comply with applicable institutional, ethical, privacy, regulatory, and publication requirements. Netra Restoration Therapy remains complementary to conventional ophthalmic care.
